Seeking Alpha

  ImmunoCellular Therapeutics, Ltd. - NYSEMKT

11/22/2014, 5:50 AM ET
  • John Motyka | Send Message 25 Jun 2011

    IMUC and LGND moving against down market. Both feature similar paradigm shifting healthcare treatment modalities. Sold MYL for LT gain.
      IMUC vs. ETF Alternatives
      Company Description
      ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.